ALLO vs FMC · rev $4.6M vs rev $1.63B
Allogene Therapeutics Inc (ALLO) versus FMC Corporation (FMC) — a side-by-side from cached financials, not a winner call.
Allogene Therapeutics Inc (ALLO) is a biotechnology company listed on US.
FMC Corporation (FMC) is a agricultural inputs company listed on NYSE.
Latest reported ALLO revenue for 2026-06-30 was $4.6M. Net income was -$85.3M. ALLO currently screens at market cap $258.1M.
Latest reported FMC revenue for 2026-06-30 was $1.63B. Net income was -$467.9M. FMC currently screens at market cap $1.50B.
ALLO currently screens at market cap $258.1M. FMC currently screens at market cap $1.50B.
Not investment advice. Open the ALLO and FMC stock pages for the full models.
Not investment advice.